News

Nvidia’s forthright ambitions to expand its drug development footprint ... What programming languages like R and Python are to data ... Recursion's work has also drawn in partnerships with ...
Recursion’s acquisition supplements its digital drug discovery vertical, further enabling its pipeline of four clinical and over 30 discovery programs . July 28, 2020 09:11 AM Eastern Daylight Time.